ERFURT and BERLIN, Germany, April 5th, 2021 – AMP Alternative Medical Products Inc. (Frankfurt: C4TA, ISIN: CA0318961038) (CSE: XCX), a pharmaceutical supplier of medical cannabis to German pharmacies, announces that…
ERFURT and BERLIN, Germany, February 10th, 2021, AMP Alternative Medical Products Inc. (Formerly AMP German Cannabis Group Inc.) (“AMP”) (CSE: XCX), (Frankfurt: C4TA, ISIN: CA0318961038), a licenced importer of medical…
ERFURT / BERLIN, Germany, January 29th, 2021 – AMP German Cannabis Group Inc. (“AMP” and or “the Company”) (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) announces that it has changed its…
ERFURT / BERLIN / DENSBORN, Germany, and LEAMINGTON, Ontario, Canada – January 26th, 2021– AMP German Cannabis Group Inc. (“AMP”) (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) and Aphria Inc.’s (“Aphria”)…
ERFURT/BERLIN, Germany, December 16th, 2020 – AMP German Cannabis Group Inc. (“AMP”) (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) is pleased to provide a letter to its shareholders. Dear Shareholders, The…
ERFURT and BERLIN, Germany, November 30th, 2020 – AMP German Cannabis Group Inc. (“AMP”) (CSE: XCX) (FSE: C4T, ISIN: CA00176G1028) is proud to present the second episode of its "Round…
ERFURT / BERLIN, Germany, and ÅRSLEV, Denmark – November 5th, 2020 – AMP German Cannabis Group Inc. (“AMP”) (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028), providing German patients with a wide…
ERFURT / BERLIN, Germany, and Perth, Western Australia - October 22nd, 2020 – AMP German Cannabis Group Inc. (“AMP”) (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028), providing German patients with a…
ERFURT and BERLIN, Germany, October 19th, 2020 – AMP German Cannabis Group Inc. (“AMP” or the “Company”) (CSE: XCX), (FSE: C4T, ISIN: CA00176G1028), providing German patients with a wide range…
ERFURT and BERLIN, Germany, October 9th, 2020, AMP German Cannabis Group Inc. (“AMP”) (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028), a licenced importer of medical cannabis into Germany, announces that its…